203 related articles for article (PubMed ID: 28153344)
21. Use of oxidized regenerated cellulose to prevent pocket hematomas after cardiac electronic device implantation in patients on anticoagulants or dual antiplatelet therapy.
Chia PL; Foo D
Int J Cardiol; 2013 Oct; 168(4):4406-7. PubMed ID: 23706282
[No Abstract] [Full Text] [Related]
22. Cardiac resynchronization therapy device implantation in patients with therapeutic international normalized ratios.
Ghanbari H; Feldman D; Schmidt M; Ottino J; Machado C; Akoum N; Wall TS; Daccarett M
Pacing Clin Electrophysiol; 2010 Apr; 33(4):400-6. PubMed ID: 20180915
[TBL] [Abstract][Full Text] [Related]
23. [Hemorrhagic risk of different perioperative anticoagulation protocols in patients implanted with a cardiac pacemaker or defibrillator: retrospective analysis in patients implanted in a community hospital].
Amara W; Ben Youssef I; Kamel J; Ghrissi I; Faron M; Khouadja A; Sergent J
Ann Cardiol Angeiol (Paris); 2009 Nov; 58(5):265-71. PubMed ID: 19833318
[TBL] [Abstract][Full Text] [Related]
24. Hematoma complicating permanent pacemaker implantation: the role of periprocedural antiplatelet or anticoagulant therapy.
Özcan KS; Osmonov D; Yıldırım E; Altay S; Türkkan C; Ekmekçi A; Güngör B; Erdinler I
J Cardiol; 2013 Aug; 62(2):127-30. PubMed ID: 23611169
[TBL] [Abstract][Full Text] [Related]
25. Cardiovascular implantable electronic device implantation with uninterrupted dabigatran: comparison to uninterrupted warfarin.
Jennings JM; Robichaux R; McElderry HT; Plumb VJ; Gunter A; Doppalapudi H; Osorio J; Yamada T; Kay GN
J Cardiovasc Electrophysiol; 2013 Oct; 24(10):1125-9. PubMed ID: 23889767
[TBL] [Abstract][Full Text] [Related]
26. Increased risk of hematoma with uninterrupted warfarin in patients undergoing implantation of subcutaneous implantable cardioverter defibrillator.
Evenson C; Saour B; Afzal MR; Knight B; Okabe T; Weiss R
Pacing Clin Electrophysiol; 2019 Aug; 42(8):1111-1114. PubMed ID: 31231810
[TBL] [Abstract][Full Text] [Related]
27. Perioperative management of oral anticoagulation in patients undergoing implantation of subcutaneous implantable cardioverter-defibrillator.
Afzal MR; Mehta D; Evenson C; Pinkhas D; Badin A; Patel D; Essandoh MK; Godara H; Tyler J; Houmsse M; Liu Z; Kalbfleisch SJ; Hummel JD; Augostini R; Weiss R; Daoud EG; Okabe T
Heart Rhythm; 2018 Apr; 15(4):520-523. PubMed ID: 29146276
[TBL] [Abstract][Full Text] [Related]
28. Predictors of pocket hematoma in patients on antithrombotic therapy undergoing cardiac rhythm device implantation: insights from the FinPAC trial.
Nammas W; Raatikainen MJ; Korkeila P; Lund J; Ylitalo A; Karjalainen P; Virtanen V; Koivisto UM; Utriainen S; Vasankari T; Koistinen J; Airaksinen KE
Ann Med; 2014 May; 46(3):177-81. PubMed ID: 24785546
[TBL] [Abstract][Full Text] [Related]
29. Rationale, study design, and pilot phase of tHE Management of AntiThrOMbotic therApy (HEMATOMA) in patients undergoing electrophysiological device surgery: Italian National Multicenter Observational REgistry.
Zacà V; Breschi M; Mandorli A; Panchetti L; Ricciardi G; Viani S; Notarstefano P
J Cardiovasc Med (Hagerstown); 2017 Nov; 18(11):897-899. PubMed ID: 28594654
[TBL] [Abstract][Full Text] [Related]
30. Current strategies to minimize postoperative hematoma formation in patients undergoing cardiac implantable electronic device implantation: A review.
Mehta NK; Doerr K; Skipper A; Rojas-Pena E; Dixon S; Haines DE
Heart Rhythm; 2021 Apr; 18(4):641-650. PubMed ID: 33242669
[TBL] [Abstract][Full Text] [Related]
31. Perioperative anticoagulation management in patients on chronic oral anticoagulant therapy undergoing cardiac devices implantation: a meta-analysis.
Du L; Zhang Y; Wang W; Hou Y
Pacing Clin Electrophysiol; 2014 Nov; 37(11):1573-86. PubMed ID: 25234639
[TBL] [Abstract][Full Text] [Related]
32. Perioperative anticoagulation in patients having implantation of a cardiac pacemaker or defibrillator: a systematic review and practical management guide.
Jamula E; Douketis JD; Schulman S
J Thromb Haemost; 2008 Oct; 6(10):1615-21. PubMed ID: 18638011
[TBL] [Abstract][Full Text] [Related]
33. Perioperative hematoma with subcutaneous ICD implantation: Impact of anticoagulation and antiplatelet therapies.
Sheldon SH; Cunnane R; Lavu M; Parikh V; Atkins D; Reddy YM; Berenbom LD; Emert MP; Pimentel R; Dendi R; Lakkireddy DR
Pacing Clin Electrophysiol; 2018 Jul; 41(7):799-806. PubMed ID: 29659027
[TBL] [Abstract][Full Text] [Related]
34. Anticoagulation and antiplatelet therapy in implantation of electrophysiological devices.
Korantzopoulos P; Letsas KP; Liu T; Fragakis N; Efremidis M; Goudevenos JA
Europace; 2011 Dec; 13(12):1669-80. PubMed ID: 21788280
[TBL] [Abstract][Full Text] [Related]
35. Bleeding complications during cardiac electronic device implantation in patients receiving antithrombotic therapy: is there any value of local tranexamic acid?
Beton O; Saricam E; Kaya H; Yucel H; Dogdu O; Turgut OO; Berkan O; Tandogan I; Yilmaz MB
BMC Cardiovasc Disord; 2016 Apr; 16():73. PubMed ID: 27105588
[TBL] [Abstract][Full Text] [Related]
36. Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator implantation.
Ahmed I; Gertner E; Nelson WB; House CM; Dahiya R; Anderson CP; Benditt DG; Zhu DW
Heart Rhythm; 2010 Jun; 7(6):745-9. PubMed ID: 20176137
[TBL] [Abstract][Full Text] [Related]
37. Local gentamicin-collagen sponge reduces cardiovascular implantable electronic device infections and pocket hematoma.
Monaco C; Barone L; Cammalleri V; Stifano G; Magliano G; Geuna F; Romeo F; Sergi D
Eur Rev Med Pharmacol Sci; 2022 Jul; 26(14):5218-5224. PubMed ID: 35916820
[TBL] [Abstract][Full Text] [Related]
38. Management of Perioperative Anticoagulation for Device Implantation.
Stewart MH; Morin DP
Card Electrophysiol Clin; 2018 Mar; 10(1):99-109. PubMed ID: 29428146
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of a new standardized protocol for the perioperative management of chronically anticoagulated patients receiving implantable cardiac arrhythmia devices.
Cano O; Muñoz B; Tejada D; Osca J; Sancho-Tello MJ; Olagüe J; Castro JE; Salvador A
Heart Rhythm; 2012 Mar; 9(3):361-7. PubMed ID: 22001709
[TBL] [Abstract][Full Text] [Related]
40. Bleeding risk of submuscular ICD implantation with continued oral anticoagulation versus heparin bridging therapy.
Pecha S; Ayikli A; Wilke I; Hakmi S; Yildirim Y; Gosau N; Reichenspurner H; Willems S; Aydin MA
Heart Vessels; 2018 Apr; 33(4):441-446. PubMed ID: 29030709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
